World Cancer Congress Kolkata | International Cancer Conference World Cancer Congress - 2017 by Echo Health
CANCER IN A NEW WAY : INNOVATION, PREVENTION, DIAGNOSIS AND CURE
World Cancer Congress Kolkata | International Cancer Conference World Cancer Congress - 2017 by Raytheon Health World Cancer Congress Kolkata | International Cancer Conference World Cancer Congress - 2017 by Echo Health
  • Cancer is among the leading causes of death worldwide.
  • In 2012, there were 14 million new cases and 8.2 million cancer-related deaths worldwide.
  • The number of new cancer cases will rise to 22 million within the next two decades
  • More than 60 percent of the world new cancer cases occur in Africa, Asia, and Central and South America
  • wowslider.net
  • The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014
Cancer is among the leading causes of death worldwide.1 In 2012, there were 14 million new cases and 8.2 million cancer-related deaths worldwide.2 The number of new cancer cases will rise to 22 million within the next two decades3 More than 60 percent of the world new cancer cases occur in Africa, Asia, and Central and South America4 The number of cancer deaths is 171.2 per 100,000 men and women per year5 The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 20146
css slider by WOWSlider.com v8.7
World Cancer Congress Kolkata | International Cancer Conference World Cancer Congress - 2017 by Arjyopa Healthcare


THYROID CANCER

What is Thyroid cancer

The thyroid is a gland at the base of the throat near the windpipe. It is shaped like a butterfly, with a right lobe and a left lobe. A thin piece of tissue connects the two lobes. The thyroid makes hormones that help control heart rate, blood pressure, body temperature, and weight.

There are four types of thyroid cancer. These are papillary, follicular, medullary, and anaplastic thyroid cancer. Papillary is the most common type of thyroid cancer.

Anaplastic thyroid cancer is hard to cure with current treatment. Other types of thyroid cancer can usually be cured.

Being exposed to radiation to the head and neck as a child increases the risk of thyroid cancer. Having certain genetic conditions such as familial medullary thyroid cancer, multiple endocrine neoplasia type 2A syndrome, and multiple endocrine neoplasia type 2B syndrome can also increase the risk of thyroid cancer.



Key Points



A Snapshot of Thyroid Cancer

Thyroid cancer is the ninth most common cancer in the United States. In 2014, it is estimated that nearly 63,000 Americans will be diagnosed with thyroid cancer, and nearly 1,900 will die of the disease. The overall in<>cidence of thyroid cancer in the United States has increased in people of all racial/ethnic groups and in both males and females over the past several decades.

The incidence of thyroid cancer is increasing more rapidly than that of any other cancer in the United States. Some, although not all, of this increase can be explained by improved detection methods. Thyroid cancer incidence rates vary by both sex and race, with incidence being nearly three times higher in women than in men and nearly twice as high in whites as in African Americans. After whites, Asians/Pacific islanders have the second highest incidence. Overall mortality rates remain low despite rising an average of 0.8% annually from 2002-2011.

Most people who develop thyroid cancer are between age 25 and 65 years. Risk factors for thyroid cancer include being female, exposure to radiation to the head and neck as a child, exposure to radioactive fallout, a personal history of goiter, a family history of thyroid disease or thyroid cancer, certain genetic conditions, and Asian ancestry. There are no routine screening tests for thyroid cancer. Standard treatments for thyroid cancer include surgery, radiation therapy (including radioactive iodine therapy), chemotherapy, thyroid hormone therapy and targeted therapy.



World Cancer Congress Kolkata | International Cancer Conference World Cancer Congress - 2017 by Echo Health

@ World Cancer Congress - 2017, Raytheon Healthcare

Designed and Developed by Raytheon Technology